Form 8-K - Current report:
SEC Accession No. 0000950170-25-077089
Filing Date
2025-05-23
Accepted
2025-05-23 17:10:09
Documents
11
Period of Report
2025-05-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20250523.htm   iXBRL 8-K 52242
2 EX-3.1 apvo-ex3_1.htm EX-3.1 21914
  Complete submission text file 0000950170-25-077089.txt   192389

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250523.xsd EX-101.SCH 26999
13 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250523_htm.xml XML 5106
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 25983338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)